Dyne Therapeutics, Inc. (DYN)
17.16
+1.24
(+7.79%)
USD |
NASDAQ |
May 20, 12:52
Dyne Therapeutics EPS Diluted (Quarterly) : -0.7323 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Biogen, Inc. | 2.153 |
| Insmed, Inc. | -0.7591 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -120.85M |
| Total Expenses (Quarterly) | 120.85M |
| Enterprise Value | 1.835B |
| Earnings Yield | -18.80% |
| Normalized Earnings Yield | -18.80 |